Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.

Urology 20120801

Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat.

BJU international 20120701

Excitatory effect of propiverine hydrochloride on urethral activity in rats.

International journal of urology : official journal of the Japanese Urological Association 20120601

Re: silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

The Journal of urology 20120501

Silodosin: erectile and ejaculatory disorders.

Prescrire international 20120501

Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.

Journal of pharmacy practice 20120401

New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.

International journal of urology : official journal of the Japanese Urological Association 20120401

Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized rats.

European journal of pharmacology 20120315

Silodosin and its potential for treating premature ejaculation: a preliminary report.

International journal of urology : official journal of the Japanese Urological Association 20120301

Benign prostatic hyperplasia: from bench to clinic.

Korean journal of urology 20120301

α-Blockers for benign prostatic hyperplasia: the new era.

Current opinion in urology 20120101

Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.

Biological & pharmaceutical bulletin 20120101

Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

BJU international 20111201

Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.

International journal of radiation oncology, biology, physics 20111115

Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.

International journal of urology : official journal of the Japanese Urological Association 20111101

[Medical expulsive therapy facilitated by alpha 1 adrenoceptor antagonist].

Clinical calcium 20111001

Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report.

Drugs & aging 20111001

Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones.

International journal of urology : official journal of the Japanese Urological Association 20110901

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

International neurourology journal 20110901

α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

British journal of clinical pharmacology 20110801

Re: Christopher R. Chapple, Francesco Montorsi, Teuvo L.J. Tammela, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 2011;59:342-52.

European urology 20110801

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.

The Journal of urology 20110701

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.

Prostate cancer and prostatic diseases 20110601

[Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia].

Hinyokika kiyo. Acta urologica Japonica 20110601

Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia.

Drugs 20110507

Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction.

Neurourology and urodynamics 20110301

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

European urology 20110301

Does the use of silodosin to treat benign prostatic hyperplasia really offer something new?

European urology 20110301

Characterization of α1-adrenoceptor subtypes mediating contraction in human isolated ureters.

Urology 20110301

Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20110301

Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.

Cancer prevention research (Philadelphia, Pa.) 20110101

BHP: Silodosin an effective new drug for BPH-associated LUTS.

Nature reviews. Urology 20110101

(RS)-1-[5-(2-Chloro-prop-yl)indolin-1-yl]ethanone.

Acta crystallographica. Section E, Structure reports online 20110101

A randomized crossover study comparing patient preference for tamsulosin and silodosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.

The Journal of international medical research 20110101

Silodosin.

Prescrire international 20110101

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia.

Clinical interventions in aging 20110101

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia.

Therapeutics and clinical risk management 20110101

Safety and pharmacokinetic studies of silodosin, a new α1A-adrenoceptor selective antagonist, in healthy Chinese male subjects.

Biological & pharmaceutical bulletin 20110101

Efficacy of electroacupuncture at Zhongliao point (BL33) for mild and moderate benign prostatic hyperplasia: study protocol for a randomized controlled trial.

Trials 20110101

Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia.

Urology 20101201

Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.

Pharmacotherapy 20101201

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20101101

Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity.

World journal of urology 20101001

Role of supraspinal and spinal alpha1-adrenergic receptor subtypes in micturition reflex in conscious rats.

American journal of physiology. Renal physiology 20101001

Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20101001

Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20101001

(RS)-1-(1-Acetyl-indolin-5-yl)-2-chloro-propan-1-one.

Acta crystallographica. Section E, Structure reports online 20100701

Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

Clinical pharmacology and therapeutics 20100501

Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia.

Neurourology and urodynamics 20100401

Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice.

Clinical and experimental nephrology 20100401

Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men.

Urology 20100301

Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men.

The journal of sexual medicine 20100301

Visualization and tissue distribution of alpha1L-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin.

The Journal of urology 20100201

Silodosin for benign prostatic hyperplasia.

The Annals of pharmacotherapy 20100201

New Drugs2010, PART 1.

Nursing 20100201

Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.

The Journal of urology 20100101

[Investigation of adverse events and the continuance rate of silodosin in all patients who received silodosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20100101

The add-on effect of solifenacin for patients with remaining overactive bladder after treatment with tamsulosin for lower urinary tract symptoms suggestive of benign prostatic obstruction.

Advances in urology 20100101

Silodosin in the treatment of benign prostatic hyperplasia.

Drug design, development and therapy 20100101

Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter.

World journal of urology 20091201

Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study.

Urology 20091201

Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.

The Journal of urology 20091201

Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101

Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia.

Clinical therapeutics 20091101

Expression of distinct alpha 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits.

British journal of pharmacology 20090901

Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.

International journal of impotence research 20090901

Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter.

Urology 20090801

Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20090801

Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.

European journal of pharmacology 20090624

Short- and long-term effects of silodosin, a selective alpha 1A-adrenoceptor antagonist, on ejaculatory function in rats.

BJU international 20090601

Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

The Journal of urology 20090601

Silodosin (Rapaflo) for benign prostatic hyperplasia.

The Medical letter on drugs and therapeutics 20090112

Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.

Neurourology and urodynamics 20090101

New drugs: milnacipran hydrochloride, fesoterodine fumarate, and silodosin.

Journal of the American Pharmacists Association : JAPhA 20090101

Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

Reviews in urology 20090101

Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.

British journal of pharmacology 20081201

[Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia].

Hinyokika kiyo. Acta urologica Japonica 20081201

Computational studies of the binding site of alpha1A-adrenoceptor antagonists.

Journal of molecular modeling 20081001

Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography.

International journal of urology : official journal of the Japanese Urological Association 20081001

Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association 20081001

The involvement of urothelial alpha1A adrenergic receptor in controlling the micturition reflex.

Biomedical research (Tokyo, Japan) 20081001

Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers.

The journal of sexual medicine 20080901

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20080601

Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations.

European journal of pharmacology 20080428

Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.

British journal of pharmacology 20080401

Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay.

Biological & pharmaceutical bulletin 20080401

In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.

European journal of pharmacology 20080202

Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Expert opinion on investigational drugs 20071201

Expressions and mechanical functions of alpha1-adrenoceptor subtypes in hamster ureter.

European journal of pharmacology 20071114

Alpha1-adrenoceptors and ejaculatory function.

British journal of pharmacology 20071001

Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.

Biological & pharmaceutical bulletin 20070701

Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding.

The Journal of urology 20070101

Search for new alpha1a-adrenoceptor-selective antagonist for treating lower urinary tract symptoms associated with benign prostatic hyperplasia.

Indian journal of urology : IJU : journal of the Urological Society of India 20070101

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

BJU international 20061101

[Pharmacological and clinical profile of silodosin (URIEF Cap. 2 mg, 4 mg)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20061001

A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.

The Journal of urology 20060901

[Alpha1-adrenoceptor subtypes and alpha1-adrenoceptor antagonists].